August 2022

A joint educational session with the European Society for Radiotherapy & Oncology will consider where radiation best fits amid new lung cancer treatment trends involving immunotherapies, biomarkers, and more.

An expert panel will share strategies for managing COVID-19 challenges and encourage attendees to support research on the disease’s implications on risk of lung cancer.

There will be no shortage of opportunities to enjoy music or drinks—or both at the same time—when you step out on the town during WCLC 2022.

Honorees Drs. Raymond Osarogiagbon, Wen-Zhao Zhong, and Patrick Forde will give the first three of nine state-of-the-art award lectures on Sunday afternoon, August 7, during WCLC.

Identifying those at high risk and limiting the number of missed cancers is essential for lung cancer screening to fulfill its revolutionary promise.

Lung cancer screening should remain available during respiratory infection outbreaks, epidemics, or pandemics, but some considerations are needed.

During today’s IASLC Awards Ceremony, the association honored four leaders in the lung cancer community for their achievements in the field.

A complement to the Journal of Thoracic Oncology, JTO Clinical and Research Reports is the official open access journal of IASLC.

In a Q&A with ILCN, Dr. Heather Wakelee discusses her favorite WCLC events, her outlook on the prevention, screening, and treatment of thoracic cancers, and more.

Researchers have demonstrated the need for, and benefits of, increased screening efforts in Brazil. While barriers exist—from the country’s vast size to unequal access to healthcare—progress is being made.